Actrapid and Nitroglycerin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Actrapid (insulin) and Nitroglycerin (nitroglycerin). Common drug interactions include hypercholesterolaemia among females and dry skin among males.

The phase IV clinical study analyzes what interactions people have when they take Actrapid and Nitroglycerin. It is created by eHealthMe based on reports of 38 people who take the same drugs from the FDA, and is updated regularly.

What is Actrapid?

Actrapid has active ingredients of insulin. eHealthMe is studying from 4,864 Actrapid users. Check the latest studies of Actrapid.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.



On Aug, 12, 2026

38 people who take Actrapid and Nitroglycerin together, and have interactions are studied.

Actrapid and Nitroglycerin drug interactions.

What are the common drug interactions of Actrapid and Nitroglycerin, by gender? *:

female:

  1. Hypercholesterolaemia (high levels of cholesterol in the blood)
  2. Hyperglycaemia (high blood sugar)
  3. Hypertension (high blood pressure)
  4. Hypokalaemia (low potassium)
  5. Ill-defined disorder
  6. Injury
  7. Insulin-requiring type 2 diabetes mellitus
  8. Migraine (headache)
  9. Nausea (feeling of having an urge to vomit)
  10. Obesity (having too much body fat)

male:

  1. Dry skin
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Blood pressure increased
  4. C-reactive protein increased
  5. Gait disturbance
  6. Mobility decreased (ability to move is reduced)
  7. Myalgia (muscle pain)
  8. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  9. Pain
  10. Pain in extremity

What are the common drug interactions of Actrapid and Nitroglycerin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Depression
  2. Empty sella syndrome (pituitary gland shrinks or becomes flattened)
  3. Essential hypertension (primary hypertension)
  4. Facial pain
  5. Fluid overload (too much fluid in the blood)
  6. Genital candidiasis (candidiasis (fungus)infection of genital)
  7. Hypercholesterolaemia (high levels of cholesterol in the blood)
  8. Hyperglycaemia (high blood sugar)
  9. Hypertension (high blood pressure)
  10. Hypokalaemia (low potassium)

60+:

  1. Dry skin
  2. Dyspnoea exertional (breathlessness or shortness of breath)
  3. Bacterial test positive
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood pressure increased
  6. C-reactive protein increased
  7. Gait disturbance
  8. Mobility decreased (ability to move is reduced)
  9. Myalgia (muscle pain)
  10. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)

What are the existing conditions these people have? *

  1. Diabetes: 8 people, 21.05%
  2. High Blood Pressure: 7 people, 18.42%
  3. Constipation: 5 people, 13.16%
  4. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 4 people, 10.53%
  5. Type 2 Diabetes: 4 people, 10.53%
  6. Pain: 4 people, 10.53%
  7. Dry Eyes (lack of adequate tears): 3 people, 7.89%
  8. Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 7.89%
  9. Gastroenteritis (inflammation of stomach and intestine): 3 people, 7.89%
  10. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 3 people, 7.89%

* Approximation only. Some reports may have incomplete information.

Do you take Actrapid and Nitroglycerin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Actrapid and Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Actrapid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nitroglycerin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Actrapid and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nitroglycerin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on insulin and nitroglycerin (the active ingredients of Actrapid and Nitroglycerin, respectively), and Actrapid and Nitroglycerin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: